Association between vitamin D status and cognitive impairment in acute ischemic stroke patients: A prospective cohort study

Clinical Interventions in Aging

Volumn 13, Issue , 2018, Pages 2503-2509

  Chen, Huijun ^a   Liu, Yuntao ^a   Huang, Guiqian ^a   Zhu, Jie ^b   Feng, Wenqian ^b   He, Jincai ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cognitive impairment; Ischemic stroke; Mini mental state examination; Vitamin D

Indexed keywords

VITAMIN D;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; EDUCATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; CEREBROVASCULAR ACCIDENT; COMPLICATION; MIDDLE AGED; RISK FACTOR;

AGED; BRAIN ISCHEMIA; COGNITIVE DYSFUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85058690800     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S187142     Document Type: Article

References (44)

1. de Haan EH, Nys GM, van Zandvoort MJ. Cognitive function following stroke and vascular cognitive impairment. Curr Opin Neurol. 2006;19(6):559–564.
2. Jokinen H, Melkas S, Ylikoski R, et al. Post-stroke cognitive impairment is common even after successful clinical recovery. Eur J Neurol. 2015;22(9):1288–1294.
3. Nys GM, van Zandvoort MJ, van der Worp HB, et al. Early cognitive impairment predicts long-term depressive symptoms and quality of life after stroke. J Neurol Sci. 2006;247(2):149–156.
4. Lee M, Saver JL, Hong KS, et al. Cognitive impairment and risk of future stroke: a systematic review and meta-analysis. CMAJ. 2014; 186(14):E536–E546.
5. Sarfo FS, Akassi J, Adamu S, Obese V, Ovbiagele B. Burden and predictors of poststroke cognitive impairment in a sample of Ghanaian stroke survivors. J Stroke Cerebrovasc Dis. 2017;26(11):2553–2562.
6. Gottesman RF, Hillis AE. Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke. Lancet Neurol. 2010;9(9): 895–905.
7. Barnard K, Colón-Emeric C. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother. 2010;8(1):4–33.
8. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340–1349.
9. Resnick LM, Müller FB, Laragh JH. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med. 1986;105(5):649–654.
10. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002;13(3):100–105.
11. Annweiler C, Bartha R, Goncalves S, et al. Vitamin D-related changes in intracranial volume in older adults: a quantitative neuroimaging study. Maturitas. 2015;80(3):312–317.
12. Gezen-Ak D, Yılmazer S, Dursun E. Why vitamin D in Alzheimer’s disease? The hypothesis. J Alzheimers Dis. 2014;40(2):257–269.
13. Grant WB. Does vitamin D reduce the risk of dementia? J Alzheimers Dis. 2009;17(1):151–159.
14. Pogge E, Vitamin D. Vitamin D and Alzheimer’s disease: is there a link? Consult Pharm. 2010;25(7):440–450.
15. Matchar DB, Chei CL, Yin ZX, et al. Vitamin D levels and the risk of cognitive decline in Chinese elderly people: the Chinese longitudinal healthy longevity survey. J Gerontol A Biol Sci Med Sci. 2016;71(10): 1363–1368.
16. Annweiler C, Milea D, Whitson HE, et al. Vitamin D insufficiency and cognitive impairment in Asians: a multi-ethnic population-based study and meta-analysis. J Intern Med. 2016;280(3):300–311.
17. Feart C, Helmer C, Merle B, et al. Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer’s disease in older adults. Alzheimers Dement. 2017;13(11):1207–1216.
18. Xu T, Zhong C, Peng Y, et al. Serum 25-hydroxyvitamin D deficiency predicts poor outcome amongst acute ischaemic stroke patients with low high density lipoprotein cholesterol. Eur J Neurol. 2016; 23(12):1763–1768.
19. Narasimhan S, Balasubramanian P. Role of vitamin D in the outcome of ischemic stroke-A randomized controlled trial. J Clin Diagn Res. 2017;11(2):Cc06–Cc10.
20. Daubail B, Jacquin A, Guilland JC, et al. Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients. Eur J Neurol. 2013;20(1):57–61.
21. Tu WJ, Zhao SJ, Xu DJ, Chen H. Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic stroke. Clin Sci. 2014;126(5):339–346.
22. Yalbuzdag SA, Sarifakioglu B, Afsar SI, et al. Is 25(OH)D associated with cognitive impairment and functional improvement in stroke? A retrospective clinical study. J Stroke Cerebrovasc Dis. 2015;24(7):1479–1486.
23. Zhang Z, Hong X, Hui LI. [The minimental state examination in the Chinese residents population aged 55 years and over in the urban and rural areas of Beijing]. Chin J Neurol. 1999;32:1–7. Chinese.
24. Ross AC, Manson JE, Abrams SA, et al. The 2011 dietary reference intakes for calcium and vitamin D: what dietetics practitioners need to know. J Am Diet Assoc. 2011;111(4):524–527.
25. Davydow DS, Levine DA, Zivin K, Katon WJ, Langa KM. The association of depression, cognitive impairment without dementia, and dementia with risk of ischemic stroke: a cohort study. Psychosom Med. 2015;77(2):200–208.
26. Levine DA, Davydow DS, Hough CL, Langa KM, Rogers MA, Iwashyna TJ. Functional disability and cognitive impairment after hospitalization for myocardial infarction and stroke. Circ Cardiovasc Qual Outcomes. 2014;7(6):863–871.
27. Wang A, Liu J, Meng X, et al. Association between oxidized low-density lipoprotein and cognitive impairment in patients with ischemic stroke. Eur J Neurol. 2018;25(1):185–191.
28. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006–1018.
29. Corraini P, Henderson VW, Ording AG, Pedersen L, Horváth-Puhó E, Sørensen HT. Long-term risk of dementia among survivors of ischemic or hemorrhagic stroke. Stroke. 2017;48(1):180–186.
30. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the mini-mental state examination by age and educational level. JAMA. 1993;269(18):2386–2391.
31. Karp A, Kåreholt I, Qiu C, Bellander T, Winblad B, Fratiglioni L. Relation of education and occupation-based socioeconomic status to incident Alzheimer’s disease. Am J Epidemiol. 2004;159(2):175–183.
32. Annweiler C, Schott AM, Berrut G, et al. Vitamin D and ageing: neurological issues. Neuropsychobiology. 2010;62(3):139–150.
33. Eyles DW, Smith S, Kinobe R, Hewison M, Mcgrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21–30.
34. Brouwer-Brolsma EM, de Groot LC. Vitamin D and cognition in older adults: an update of recent findings. Curr Opin Clin Nutr Metab Care. 2015;18(1):11–16.
35. Landel V, Annweiler C, Millet P, Morello M, Féron F. Vitamin D, Cognition and Alzheimer’s disease: The therapeutic benefit is in the D-Tails. J Alzheimers Dis. 2016;53(2):419–444.
36. Garcion E, Nataf S, Berod A, Darcy F, Brachet P. 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res Mol Brain Res. 1997;45(2):255–267.
37. Dawson VL, Dawson TM. Nitric oxide actions in neurochemistry. Neurochem Int. 1996;29(2):97–110.
38. Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006;69(1): 33–43.
39. Grübler MR, März W, Pilz S, et al. Vitamin-D concentrations, cardiovascular risk and events – a review of epidemiological evidence. Rev Endocr Metab Disord. 2017;18(2):259–272.
40. Fernandes de Abreu DA, Eyles D, Féron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009;34(Suppl 1):S265–S277.
41. Schindowski K, Belarbi K, Buée L. Neurotrophic factors in Alzheimer’s disease: role of axonal transport. Genes Brain Behav. 2008;7(Suppl 1): 43–56.
42. Kalueff AV, Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care. 2007;10(1): 12–19.
43. Skaria J, Katiyar BC, Srivastava TP, Dube B. Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand. 1975;51(1): 37–58.
44. Naito H, Nezu T, Hosomi N, et al. Controlling nutritional status score for predicting 3-mo functional outcome in acute ischemic stroke. Nutrition. 2018;55–56:1–6.